A team of CRA transfer pricing consultants was engaged by a leading global medical device company to provide global transfer pricing advisory. CRA’s team has been instrumental in all parts of its transfer pricing analyses, including IP onshoring, planning, global documentation compliance, audit support, quarterly/year-end support as needed.
Highlights from 2025 and looking forward to 2026
In the United States, 2025 brought major activity in high profile transfer pricing disputes and reaffirmed how closely transfer pricing, tariffs, and customs...